US20040122000A1
(en)
|
1981-01-07 |
2004-06-24 |
Vertex Pharmaceuticals Incorporated. |
Inhibitors of aspartyl protease
|
US6878728B1
(en)
|
1999-06-11 |
2005-04-12 |
Vertex Pharmaceutical Incorporated |
Inhibitors of aspartyl protease
|
DE3721855A1
(en)
*
|
1987-03-12 |
1988-09-22 |
Merck Patent Gmbh |
AMINO ACID DERIVATIVES
|
GB8707412D0
(en)
*
|
1987-03-27 |
1987-04-29 |
Fujisawa Pharmaceutical Co |
Peptide compounds
|
DE3717631A1
(en)
*
|
1987-05-26 |
1988-12-15 |
Merck Patent Gmbh |
AMINO ACID DERIVATIVES
|
DE3814325A1
(en)
*
|
1988-04-28 |
1989-11-09 |
Merck Patent Gmbh |
AMINOSAEUREDERIVATE
|
JPH02191240A
(en)
*
|
1989-01-18 |
1990-07-27 |
Adeka Argus Chem Co Ltd |
Optically active naphthyl ester compound
|
TW225540B
(en)
*
|
1990-06-28 |
1994-06-21 |
Shionogi & Co |
|
DE69132423T2
(en)
|
1990-11-19 |
2001-04-26 |
Monsanto Co., St. Louis |
Retroviral protease inhibitors
|
US5583238A
(en)
*
|
1990-11-19 |
1996-12-10 |
G. D. Searle & Co. |
Method for making intermediates useful in synthesis of retroviral protease inhibitors
|
US5475013A
(en)
*
|
1990-11-19 |
1995-12-12 |
Monsanto Company |
Retroviral protease inhibitors
|
US5614522A
(en)
*
|
1990-11-19 |
1997-03-25 |
G.D. Searle & Co. |
Retroviral protease inhibitors
|
CA2096407C
(en)
*
|
1990-11-19 |
2007-10-02 |
Kathryn Lea Reed |
Retroviral protease inhibitors
|
US5475027A
(en)
*
|
1990-11-19 |
1995-12-12 |
G.D. Searle & Co. |
Retroviral protease inhibitors
|
US5482947A
(en)
|
1990-11-19 |
1996-01-09 |
Talley; John J. |
Retroviral protease inhibitors
|
ATE170169T1
(en)
*
|
1990-11-19 |
1998-09-15 |
Monsanto Co |
RETROVIRAL PROTEASE INHIBITORS
|
US5648511A
(en)
*
|
1990-11-19 |
1997-07-15 |
G.D. Searle & Co. |
Method for making intermediates useful in the synthesis of retroviral protease inhibitors
|
US5708004A
(en)
*
|
1990-11-19 |
1998-01-13 |
Monsanto Company |
Retroviral protease inhibitors
|
AU662114B2
(en)
*
|
1990-11-19 |
1995-08-24 |
Monsanto Company |
Retroviral protease inhibitors
|
EP0641333B1
(en)
*
|
1992-05-20 |
1996-08-14 |
G.D. Searle & Co. |
Method for making intermediates useful in synthesis of retroviral protease inhibitors
|
JPH07508020A
(en)
|
1992-05-21 |
1995-09-07 |
ジー.ディー.サール アンド カンパニー |
Retroviral protease inhibitor
|
US5559256A
(en)
*
|
1992-07-20 |
1996-09-24 |
E. R. Squibb & Sons, Inc. |
Aminediol protease inhibitors
|
US5463104A
(en)
*
|
1992-08-25 |
1995-10-31 |
G. D. Searle & Co. |
Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
|
US7141609B2
(en)
|
1992-08-25 |
2006-11-28 |
G.D. Searle & Co. |
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
|
RU2146668C1
(en)
|
1992-08-25 |
2000-03-20 |
Джи Ди Сирл энд Компани |
Sulfonylalkanoylamino-hydroxyethylamino-sulfonamide compound, pharmaceutical compositions and methods of treatment and inhibition of retroviral proteases
|
US6022994A
(en)
|
1992-08-25 |
2000-02-08 |
G. D. Searle &. Co. |
Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
|
US5760076A
(en)
*
|
1992-08-25 |
1998-06-02 |
G.D Searle & Co. |
Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
|
US5968942A
(en)
|
1992-08-25 |
1999-10-19 |
G. D. Searle & Co. |
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
|
US6743929B1
(en)
|
1992-08-25 |
2004-06-01 |
G. D. Searle & Co. |
Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
|
DK0656887T3
(en)
|
1992-08-25 |
1999-07-05 |
Searle & Co |
Hydroxyethylaminosulfonamides for use as inhibitors of retroviral proteases
|
US6046190A
(en)
*
|
1992-08-25 |
2000-04-04 |
G.D. Searle & Co. |
Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
|
US5830897A
(en)
*
|
1992-08-27 |
1998-11-03 |
G. D. Searle & Co. |
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
|
IS2334B
(en)
|
1992-09-08 |
2008-02-15 |
Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) |
Aspartyl protease inhibitor of a new class of sulfonamides
|
US5723490A
(en)
*
|
1992-09-08 |
1998-03-03 |
Vertex Pharmaceuticals Incorporated |
THF-containing sulfonamide inhibitors of aspartyl protease
|
US5783701A
(en)
|
1992-09-08 |
1998-07-21 |
Vertex Pharmaceuticals, Incorporated |
Sulfonamide inhibitors of aspartyl protease
|
ES2134924T3
(en)
*
|
1992-10-30 |
1999-10-16 |
Searle & Co |
SULFONILALCANOYLAMINO-HYDROXYETHYLAMINE-SULPHAMIC ACIDS USEFUL AS RETROVIRAL PROTEASE INHIBITORS.
|
US5756498A
(en)
*
|
1992-10-30 |
1998-05-26 |
G.D. Searle & Co. |
Sulfonylalkanoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
|
DE69331421T2
(en)
|
1992-10-30 |
2002-08-01 |
G.D. SEARLE & CO., CHICAGO |
N-substituted hydroxyethylaminosulfamic acid derivatives can be used as inhibitors of retroviral proteases
|
US5578606A
(en)
|
1992-10-30 |
1996-11-26 |
G. D. Searle & Co. |
α- and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
|
US6337398B1
(en)
|
1992-10-30 |
2002-01-08 |
G.D. Searle & Co. |
Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
|
US5514801A
(en)
|
1992-12-29 |
1996-05-07 |
Monsanto Company |
Cyclic sulfone containing retroviral protease inhibitors
|
US5830888A
(en)
*
|
1993-04-16 |
1998-11-03 |
Monsanto Company |
Macrocyclic retroviral protease inhibitors
|
US5750648A
(en)
*
|
1993-08-20 |
1998-05-12 |
G.D. Searle & Co. |
Retroviral protease inhibitors and combinations thereof
|
AU7669794A
(en)
*
|
1993-08-24 |
1995-03-21 |
G.D. Searle & Co. |
Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
|
US5602119A
(en)
*
|
1993-10-29 |
1997-02-11 |
Vazquez; Michael L. |
Succinoylamino hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
|
US6133444A
(en)
*
|
1993-12-22 |
2000-10-17 |
Perseptive Biosystems, Inc. |
Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
|
ES2139195T3
(en)
*
|
1994-03-07 |
2000-02-01 |
Vertex Pharma |
SULFONAMID DERIVATIVES AS ASPARTIL-PROTEASE INHIBITORS.
|
JP4014220B2
(en)
|
1995-01-20 |
2007-11-28 |
ジー.ディー.サール アンド カンパニー |
Bis-sulfonamidohydroxyethylamino retroviral protease inhibitor
|
US5831117A
(en)
|
1995-01-20 |
1998-11-03 |
G. D. Searle & Co. |
Method of preparing retroviral protease inhibitor intermediates
|
US6140505A
(en)
|
1995-03-10 |
2000-10-31 |
G. D. Searle & Co. |
Synthesis of benzo fused heterocyclic sulfonyl chlorides
|
US5756533A
(en)
*
|
1995-03-10 |
1998-05-26 |
G.D. Searle & Co. |
Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
|
US6150556A
(en)
|
1995-03-10 |
2000-11-21 |
G. D. Dearle & Co. |
Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
|
US5705500A
(en)
*
|
1995-03-10 |
1998-01-06 |
G.D. Searle & Co. |
Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
|
US6407134B1
(en)
|
1995-03-10 |
2002-06-18 |
G. D. Searle & Co. |
Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
|
US7339078B2
(en)
|
1995-03-10 |
2008-03-04 |
G.D. Searle Llc |
Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
|
US6169085B1
(en)
|
1995-03-10 |
2001-01-02 |
G. D. Searle & Company |
Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
|
US6861539B1
(en)
|
1995-03-10 |
2005-03-01 |
G. D. Searle & Co. |
Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
|
US6667307B2
(en)
|
1997-12-19 |
2003-12-23 |
G.D. Searle & Co. |
Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
|
JP4124818B2
(en)
*
|
1995-03-10 |
2008-07-23 |
ジー.ディー.サール アンド カンパニー |
Heterocyclocarbonylamino acid hydroxyethylaminosulfonamide retroviral protease inhibitor
|
EP1188766A1
(en)
|
1995-03-10 |
2002-03-20 |
G.D. Searle & Co. |
Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
|
US5776971A
(en)
*
|
1995-03-10 |
1998-07-07 |
G.D. Searle & Co. |
Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
|
US5985870A
(en)
*
|
1995-03-10 |
1999-11-16 |
G.D. Searle & Co. |
Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
|
US5691372A
(en)
*
|
1995-04-19 |
1997-11-25 |
Vertex Pharmaceuticals Incorporated |
Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
|
US6004957A
(en)
*
|
1995-06-07 |
1999-12-21 |
Vertex Pharmaceuticals, Incorporated |
Sulfonamide inhibitors of aspartyl protease
|
CA2236236A1
(en)
*
|
1995-11-15 |
1997-05-22 |
G.D. Searle & Co. |
Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
|
US5883252A
(en)
*
|
1996-01-26 |
1999-03-16 |
Vertex Pharmaceuticals Incorporated |
Aspartyl protease inhibitors
|
US6436989B1
(en)
|
1997-12-24 |
2002-08-20 |
Vertex Pharmaceuticals, Incorporated |
Prodrugs of aspartyl protease inhibitors
|
AP1717A
(en)
|
1998-06-19 |
2007-01-30 |
Vertex Pharma |
Sulfonamide inhibitors of aspartyl protease.
|
EP1095022A1
(en)
|
1998-07-08 |
2001-05-02 |
G.D. Searle & Co. |
Retroviral protease inhibitors
|
AR031520A1
(en)
*
|
1999-06-11 |
2003-09-24 |
Vertex Pharma |
AN INHIBITOR COMPOSITE OF ASPARTILO PROTEASA, A COMPOSITION THAT INCLUDES IT AND A METHOD TO TREAT A PATIENT WITH SUCH COMPOSITION
|
WO2002014264A2
(en)
*
|
2000-08-11 |
2002-02-21 |
The Brigham And Women's Hospital, Inc. |
(hydroxyethyl)ureas as inhibitors of alzheimer's beta-amyloid production
|
WO2002050019A2
(en)
|
2000-12-20 |
2002-06-27 |
Bristol-Myers Squibb Pharma Co. |
Diamines as modulators of chemokine receptor activity
|
HUP0303652A2
(en)
|
2000-12-20 |
2004-03-01 |
Bristol-Myers Squibb Company |
Cyclic derivatives as modulators of chemokine receptor activity and pharmaceutical compositions containing them
|